Podcasts about Tripathi

If you enjoy this episode, we're sure you will enjoy more content like this on The Occult Rejects.  In fact, we have curated playlists on occult topics like grimoires, esoteric concepts and phenomena, occult history, analyzing true crime and cults with an occult lens, Para politics, and occultism in music. Whether you enjoy consuming your content visually or via audio, we've got you covered - and it will always be provided free of charge.  So, if you enjoy what we do and want to support our work of providing accessible, free content on various platforms, please consider making a donation to the links provided below.  Thank you and enjoy the episode!Links For The Occult Rejectshttps://linktr.ee/theoccultrejectsOccult Research Institutehttps://www.occultresearchinstitute.org/Cash Apphttps://cash.app/$theoccultrejectsVenmo@TheOccultRejectsBuy Me A Coffeebuymeacoffee.com/TheOccultRejectsPatreonhttps://www.patreon.com/TheOccultRejectsFull show-notes bibliographyCore EEG and oscillationsAbubaker, M., & Dankaerts, W. (2021). Working memory and cross-frequency coupling of neuronal oscillations. *Frontiers in Psychology, 12*, 742860.Axmacher, N., Henseler, M. M., Jensen, O., Weinreich, I., Elger, C. E., & Fell, J. (2010). Cross-frequency coupling supports multi-item working memory in the human hippocampus. *Proceedings of the National Academy of Sciences, 107*(7), 3228–3233.Jensen, O., & Mazaheri, A. (2010). Shaping functional architecture by oscillatory alpha activity: Gating by inhibition. *Frontiers in Human Neuroscience, 4*, 186.Rayi, A., et al. (2022). Electroencephalogram. *StatPearls*. StatPearls Publishing.StatPearls / NCBI Bookshelf. (2024). Introduction to electroencephalography (EEG). *NCBI Bookshelf*.Theta, alpha, beta, gamma, and controlCavanagh, J. F., & Shackman, A. J. (2015). Frontal midline theta reflects anxiety and cognitive control: Meta-analytic evidence. *Journal of Physiology-Paris, 109*(1–3), 3–15.Eisma, J., et al. (2021). Frontal midline theta differentiates separate cognitive control strategies while still generalizing the need for cognitive control. *Scientific Reports, 11*, 14641.Jensen, O., Bonnefond, M., & VanRullen, R. (2012). An oscillatory mechanism for prioritizing salient unattended stimuli. *Trends in Cognitive Sciences, 16*(4), 200–206.Lundqvist, M., Herman, P., & Miller, E. K. (2018). Working memory: Delay activity, yes! Persistent activity? Maybe not. *Journal of Neuroscience, 38*(32), 7013–7019.Sleep architecture, spindles, and memoryCaporro, M., Haneef, Z., Yeh, H.-J., Mohamed, F. B., & Levin, H. S. (2012). Functional MRI of sleep spindles and K-complexes. *Clinical Neurophysiology, 123*(2), 303–309.Chen, P., Miao, X., Chen, J., et al. (2023). The devastating effects of sleep deprivation on memory: Lessons from rodent models, aging, and Alzheimer's disease. *Frontiers in Neuroscience, 17*, 1151639.Ng, T., et al. (2025). Bayesian meta-analysis reveals the mechanistic role of slow oscillation-spindle coupling in sleep-dependent memory consolidation. *eLife, 13*, RP101992.Patel, A. K., et al. (2024). Physiology, sleep stages. *StatPearls*. StatPearls Publishing.Páez, A., Gillman, S. O., Dogaheh, S. B., et al. (2025). Sleep spindles and slow oscillations predict cognition and biomarkers of neurodegeneration in mild to moderate Alzheimer's disease. *Alzheimer's & Dementia, 21*, e14424.Hypnagogia, N1, and dream incubationHorowitz, A. H., Esfahany, S., Boyle, M. R., et al. (2023). Targeted dream incubation at sleep onset increases post-sleep creative performance. *Scientific Reports, 13*, 5055.Lacaux, C., Andrillon, T., Bastoul, D., et al. (2021). Sleep onset is a creative sweet spot. *Science Advances, 7*(50), eabj5866.Meditation, prayer, chanting, and yoga nidraDatta, K., Mallick, H. N., Tripathi, M., Ahuja, G. K., & Deepak, K. K. (2022). Electrophysiological evidence of local sleep during yoga nidra practice in young male volunteers. *Frontiers in Neurology, 13*, 910794.Dobrakowski, P., Błaszkiewicz, M., & Skalski, S. (2020). Changes in the electrical activity of the brain in the alpha and theta bands during prayer and meditation. *International Journal of Environmental Research and Public Health, 17*(24), 9567.Gao, J., Leung, H. K., Wu, B. W. Y., Skouras, S., & Sik, H. H. (2019). The neurophysiological correlates of religious chanting. *Scientific Reports, 9*, 4262.Kaur, C., & Singh, P. (2015). EEG derived neuronal dynamics during meditation: Progress and challenges. *Advances in Preventive Medicine, 2015*, 614723.Lomas, T., Ivtzan, I., & Fu, C. H. Y. (2015). A systematic review of the neurophysiology of mindfulness on EEG oscillations. *Neuroscience & Biobehavioral Reviews, 57*, 401–410.Hypnosis and suggestionJensen, M. P., Adachi, T., & Hakimian, S. (2015). Brain oscillations, hypnosis, and hypnotizability. *American Journal of Clinical Hypnosis, 57*(3), 230–253.Kirenskaya, A. V., Novototsky-Vlasov, V. Y., Chistyakov, A. V., & Zvonikov, V. M. (2011). Waking EEG spectral power and coherence differences between highly hypnotizable and low hypnotizable subjects. *International Journal of Clinical and Experimental Hypnosis, 59*(2), 144–164.Mendoza, M. E., & Capafons, A. (2024). Neural correlates of hypnosis: A systematic narrative review. *Frontiers in Psychology, 15*, 1327738.Ritual rhythm, trance, and synchronyHuels, E. R., Kim, H. S., Lee, U., & Mollaahmetoglu, O. M. (2021). Neural correlates of the shamanic state of consciousness. *Frontiers in Human Neuroscience, 15*, 610466.Mogan, R., Fischer, R., & Bulbulia, J. A. (2017). To be in synchrony or not? A meta-analysis of synchrony's effects on behavior, perception, cognition and affect. *Journal of Experimental Social Psychology, 72*, 13–20.Tarr, B., Launay, J., & Dunbar, R. I. M. (2016). Silent disco: Dancing in synchrony leads to elevated pain thresholds and social closeness. *Evolution and Human Behavior, 37*(5), 343–349.Entrainment, binaural beats, fatigue, and overloadGoodman, S. P. J., et al. (2025). Approaches to inducing mental fatigue: A systematic review and meta-analysis of (neuro)physiologic indices. *Neuroscience & Biobehavioral Reviews, 170*, 105957.Ingendoh, R. M., Posny, E. S., & Heine, A. (2023). Binaural beats to entrain the brain? A systematic review of the effects of binaural beat stimulation on brain oscillatory activity, and the implications for psychological research and intervention. *PLOS ONE, 18*(5), e0286023.Snipes, S., et al. (2024). Extended wakefulness alters the relationship between EEG theta and alpha bursts and behavioural outcome. *European Journal of Neuroscience, 60*(8), 6268–6284.Xiang, C., et al. (2024). A resting-state EEG dataset for sleep deprivation. *Scientific Data, 11*, 406.Parkinson's disease and pathological betaAsadi, A., et al. (2022). The origin of abnormal beta oscillations in the parkinsonian corticobasal ganglia circuit. *Frontiers in Neuroscience, 16*, 823719.Paulo, D. L., et al. (2023). Corticostriatal beta oscillation changes associated with cognitive function in Parkinson's disease. *NPJ Parkinson's Disease, 9*, 202.Ancient sleep, dreams, and Asclepian healingAskitopoulou, H. (2015). Sleep and dreams: From myth to medicine in ancient Greece. *Journal of Anesthesia History, 1*(3), 70–75.Kapotsis, G., & Steiropoulos, P. (2025). Sleep incubation [enkoimesis] in medical practice at Asclepieia of Ancient Greece — the Ancient Greek sleep medicine. *Sleep Medicine, 130*, 85–89.Pavli, A. (2024). Asclepieia in ancient Greece: pilgrimage and healing. *Journal of Integrative Medicine and Research, 3*(2), 100119.Also want to remind people about the website, if you're into reading we have tons of information by multiple contributors, and we got t-shirts up on the site if you're interested. Fun fact, the art is all based on the eyeball. A

In this episode of Sage Up With Pritika, Pritika Loonia sits down with Aryan Tripathi for an insightful agency guidebook on how to close premium clients. They delve into the nuances of client relationships, performance strategies, and the long-term vision for building a successful agency.* Understand the difference between clients motivated by money versus those seeking a good working "vibe."* Learn how to identify and manage toxic clients, and the art of effective follow-up.* Discover the power of performance-based KPIs in retaining clients and driving business growth.* Gain insights into the dedication and time required to build a reputable agency.* Actionable advice from Aryan Tripathi on closing premium clients and scaling your agency.00:00:00 - 00:01:14 - Podcast trailer00:01:14 - 00:04:45 - Agency basics and biggest mistakes00:04:45 - 00:10:27 - Standing out and client acquisition00:10:27 - 00:13:51 - Pitching mistakes and firing clients00:13:51 - 00:23:42 - Hiring and building a team00:23:42 - 00:30:28 - Leadership mistakes and managing Gen-Z00:30:28 - 00:37:25 - Why most agencies fail00:37:25 - 00:41:15 - Pricing margins and premium clients00:41:15 - 00:48:36 - Closing high ticket clients00:48:36 - End - Ads strategy and final adviceConnect With Aryan Tripathi -https://www.instagram.com/aryan_optimizer/ Instagram - Connect With Pritika -Podcast Related Emails - connect@pritika.coInstagram- https://www.instagram.com/pritika.looniaListen to the full podcast here - https://www.youtube.com/@PritikaLooniaOfficial Facebook - https://www.facebook.com/captainpritika/Learn From Me - www.pritika.co Listen to my podcast on - Jio saavn - https://www.jiosaavn.com/shows/sage-up-with-pritika-loonia/2/ZukCx7qhBVQ_ Spotify- https://open.spotify.com/show/7ErewAP263SgLXOUE8V0SI?si=f0c13ec52bb74062 Apple Podcast- https://podcasts.apple.com/in/podcast/sage-up-with-pritika-loonia/id1517629945

In this episode of Guftugu, Shweta Tripathi Sharma speaks with honesty and warmth about the choices that shaped her journey as an actor. From her early creative instincts to becoming a widely loved face through standout performances, she reflects on ambition, vulnerability, discipline, and the courage to back stories that feel true. The conversation moves through acting craft, fame after Mirzapur, personal growth, and what it takes to stay grounded in a fast-moving industry. A thoughtful listen for anyone interested in cinema, performance, storytelling, and the making of an artist with a voice of her own.

Aryan Tripathi, Founder of Adymize breaks down the exact system he uses to build and scale D2C brands on Meta from finding your winning customer persona to running ads that actually convert.If you're a founder, marketer, or someone trying to figure out why your ads aren't working, this one is for you.What you'll learn:→ The #1 mistake new D2C founders make (and it's not what you think)→ The 5 Persona Framework - how to find the exact customer who will buy→ How to steal customers from big brands using Comparison Ads→ Why 95% of brands get stuck in a scaling loop - and how to break out→ Ads vs Influencer Marketing: where should your ₹1 lakh go?→ How Repeat Rate can turn a small brand into a unicorn00:00:00 - 00:01:48 - Trailer00:01:48 - 00:03:26 - Biggest mistake new businesses make when running Ads00:03:26 - 00:05:35 - Should you love your product before it's proven? - Real talk00:05:35 - 00:09:58 - The 5 Persona Framework - How to find your winning customer (Sunscreen example)00:09:58 - 00:13:20 - Which persona to target first - Low budget vs high budget strategy00:13:20 - 00:16:40 - How to steal customers from big brands —-Comparison Ads strategy00:16:40 - 00:20:00 - Scaling a D2C brand -Why 95% get stuck in one loop00:20:00 - 00:22:40 - Fish Oil case study - How to 10x your audience with same product00:22:40 - 00:26:45 - Emotions in Ads - Why "mummy-papa ke liye" angle actually works00:26:45 - 00:30:30 - T-shirt brand from scratch - Step-by-step for small budget founders00:30:30 - 00:33:30 - Niche vs Mass product - What actually works in D2C today00:33:30 - 00:38:00 - Returns problem in D2C -How to reduce & handle it00:38:00 - 00:45:00 - Meta Ads -What's working right now, what's dead00:45:00 - 00:52:00 - Claude AI vs ChatGPT for Ad copy - Why Claude wins00:52:00 - 00:58:00 - ₹2 lakh budget - Ads vs Influencer Marketing, the real answer00:58:00 - 01:05:00 - Repeat Rate is everything - How to build a unicorn with retention01:05:00 - 01:10:00 - Conversion Rate Optimization - Landing page mistakes everyone makes01:10:00 - End - Aryan's agency journey - 21 years old, ₹70 Cr ad spend, what's nextConnect With Aryan Tripathi -https://www.instagram.com/aryan_optimizer/ Instagram - Connect With Pritika -Podcast Related Emails - connect@pritika.coInstagram- https://www.instagram.com/pritika.looniaListen to the full podcast here - https://www.youtube.com/@PritikaLooniaOfficial Facebook - https://www.facebook.com/captainpritika/Learn From Me - www.pritika.co Listen to my podcast on - Jio saavn - https://www.jiosaavn.com/shows/sage-up-with-pritika-loonia/2/ZukCx7qhBVQ_ Spotify- https://open.spotify.com/show/7ErewAP263SgLXOUE8V0SI?si=f0c13ec52bb74062 Apple Podcast- https://podcasts.apple.com/in/podcast/sage-up-with-pritika-loonia/id1517629945

Send a text

What does it take to lead a university for over two decades, and still love the work?In this special farewell episode of Start the Week with Wisdom, hosts Bridget Burns and Sarah Custer sit down with President Satish Tripathi of the University at Buffalo as he reflects on a remarkable 22-year legacy of leadership, innovation, and transformation. With retirement on the horizon, President Tripathi shares candid reflections on what's changed, what he's proudest of, and what it really takes to lead through complexity, uncertainty, and change.From moving a medical school to revitalizing a city, to pioneering national research in AI and drug discovery, Tripathi's tenure is marked by bold vision and patient execution. But beyond the milestones, he shares what shaped his leadership, from growing up in a small Indian village to navigating crises like the Great Recession and the COVID-19 pandemic. He also offers unfiltered advice for aspiring higher ed leaders, and a surprising answer about what he's looking forward to most after stepping down.Key Takeaways:→ Big change requires long-term vision: Transformational projects like relocating UB's medical school or launching NSF research centers took years, and a relentless commitment to mission.→ Naivete can be a secret weapon: Not knowing how hard something will be might just be the key to starting it at all.→ Legacy is defined by others: True leadership means focusing on impact, not recognition.→ Leadership evolves: Tripathi now leads with more listening, humility, and trust in his team than when he began.→ Great leadership isn't about the next job, it's about doing the current one with excellence.“If you're always thinking about the next job, you're not doing your current job well. Excellence now is what leads you forward.” – President Satish TripathiIf this conversation inspired you, share it with a colleague, subscribe for more wisdom-filled episodes, and take a moment to journal: what long-term impact are you building today?Learn more about the UIA by visiting:WebsiteLinkedInTwitterYouTubeFacebookThis week's episode is sponsored by Mainstay, a student retention and engagement tool where you can increase student and staff engagement with the only platform consistently proven to boost engagement, retention, and wellbeing. To learn more about Mainstay, click here.

Une équipe de chercheurs a découvert que les jets à grande échelle entraînent une forte amplification du champ magnétique, et ils ont intégré cet effet dans un nouveau scénario de dynamo distinct des modèles conventionnels généralement adoptés pour les dynamos planétaires et stellaires. Ces travaux sont particulièrement pertinents pour l'amplification du champ magnétique dans les plasmas, les planètes, les étoiles, les étoiles à neutrons et les disques d'accrétion autour d'objets compacts. Ils publient leur étude dans Nature. Source Large-scale dynamos driven by shear-flow-induced jetsB. Tripathi et al.Nature volume 649 (21 janvier 2026) Illustration Evolution à long terme d'une dynamo, montrant des phases de génération turbulente de flux et de champs magnétiques (B. Tripathi et al.). Bindesh Tripathi

This special episode podcast series, presented by Piramal Foundation in collaboration with The Good Sight, focuses on the fight against lymphatic filariasis (filaria), a neglected yet debilitating public health challenge.Our guest is Dr. Bhupendra Tripathi, Deputy Director at the Gates Foundation, who has been working extensively to support the elimination of filaria and other infectious diseases in India. His work spans strengthening vaccine delivery systems, expanding equitable immunization coverage, and ensuring that no community is left behind in public health efforts.In this episode, Dr. Tripathi explains what filaria is, how it affects the human body, and who is most at risk—using simple, accessible language. We discuss the early warning signs that should never be ignored, even when symptoms appear mild. The conversation also goes beyond medical aspects to explore how filaria impacts a person's livelihood, daily life, and social dignity, and the broader economic burden such diseases place on communities and countries, as highlighted by the World Health Organization.The episode concludes with an on-ground perspective on how India and the global community are working together to eliminate filaria, highlighting coordinated efforts by governments, institutions, and development partners to turn awareness into action and solutions.This episode reinforces a powerful message: with the right knowledge, strong systems, and collective commitment, filaria can be prevented and eliminated.CreditsGuest: Dr. Bhupendra TripathiHost: Sanjay PrasadResearch: Alisha CConcept: Piramal Foundation Produced by: The Good SightFor feedback or to participate, write to us at contact@thegoodsight.org#Filaria #LymphaticFilariasis #PublicHealth #DiseaseElimination #Immunization #HealthEquity #PiramalFoundation #TheGoodSight

In this NGPF Speaker Series episode, Tim Ranzetta interviews high school junior Sid Tripathi, founder of the Dollar Investigators, a youth-led initiative teaching elementary students foundational money skills. Sid shares how family conversations about finances and early entrepreneurship shaped his "long game" mindset around saving, investing, and avoiding get-rich-quick thinking. He explains how his team brings concepts like needs versus wants, budgeting, banking, debt, and compound interest to younger learners through hands-on activities and roleplay. Tim and Sid also discuss what motivates students, how to make financial topics immediately relevant, and what Sid has observed about teen investing apps, sports betting, and crypto hype. The conversation highlights how student-led teaching can normalize money talk, build confidence, and plant early "seeds" of financial decision-making. Educators will leave with practical ideas for engaging lessons, inspiring youth leadership, and ways to scale financial literacy impact beyond a single classroom.

Smelling onions and shoes are two of the biggest myths as a treatment for Epilepsy.  There is still a stigma to discuss about the condition.  People still hide the condition and think of it as a curse.  In this episode, we are joined by Dr Manjari Tripathi, Professor in the Department of Neurology at AIIMS Delhi, where she heads the Centre of Excellence for Epilepsy. A pioneering neurologist with over 350 publications, she has advanced epilepsy surgery techniques and trained generations of neurologists across India. Vikas & Dr Tripathi discussed in detail what epilepsy really is. Why does rural India face higher rates of epilepsy cases? The dangerous myths that prevent treatment, and the critical first aid everyone must know.Here are some key takeaways:Epilepsy is electrical chaos in the brain, not a mental illness: Hyper-excitable neurons cause short-circuits leading to seizures. It can happen at any age from preventable causes like head injuries, infections, etc.Head injuries are India's most preventable cause: From kids falling off roofs while flying kites to helmetless riders on phones, trauma leads to seizures months or years later: sleep deprivation, alcohol, and certain antibiotics lower seizure thresholds.Shoes & onions for the treatment of seizures are just baseless myths. Learn the first aid - Turn the person on their side, loosen tight clothing, time the seizure. If it lasts over 5 minutes, rush to the hospital. Recording the seizure on video helps doctors diagnose correctly.Rural India's hygiene problem & the epilepsy connection - Poor sanitation causes tapeworm eggs to reach the brain through unwashed vegetables, triggering seizures. Myths about spirits and past karma prevent families from seeking proper medical care.Provoked seizures are not epilepsy - Seizures within 24 hours to a week of stroke, low sodium, alcohol withdrawal, or acute infections are provoked seizures requiring only short-term treatment. Epilepsy means two or more unprovoked seizures needing longer treatment.About Vikas Singh:Vikas Singh, an MBA from Chicago Booth, worked at Goldman Sachs, Morgan Stanley, APGlobale, and Reliance before coming up with the idea of democratizing fitness knowledge and helping beginners get on a fitness journey. Vikas is an avid long-distance runner, building fitpage to help people learn, train, and move better.For more information on Vikas, or to leave any feedback and requests, you can reach out to him via the channels below:Instagram: @vikas_singhhLinkedIn: Vikas SinghTwitter: @vikashsingh101Subscribe To Our Newsletter For Weekly Nuggets of Knowledge!

India Sets NEW STANDARDS for Information Warfare in Op Sindoor 2.0 | Anshuman Tripathi, Sanjay Dixit

What does it take to lead a university for over two decades, and still love the work?In this special farewell episode of Start the Week with Wisdom, hosts Bridget Burns and Sarah Custer sit down with President Satish Tripathi of the University at Buffalo as he reflects on a remarkable 22-year legacy of leadership, innovation, and transformation. With retirement on the horizon, President Tripathi shares candid reflections on what's changed, what he's proudest of, and what it really takes to lead through complexity, uncertainty, and change.From moving a medical school to revitalizing a city, to pioneering national research in AI and drug discovery, Tripathi's tenure is marked by bold vision and patient execution. But beyond the milestones, he shares what shaped his leadership, from growing up in a small Indian village to navigating crises like the Great Recession and the COVID-19 pandemic. He also offers unfiltered advice for aspiring higher ed leaders, and a surprising answer about what he's looking forward to most after stepping down.Key Takeaways:Big change requires long-term vision: Transformational projects like relocating UB's medical school or launching NSF research centers took years, and a relentless commitment to mission.Naivete can be a secret weapon: Not knowing how hard something will be might just be the key to starting it at all.Legacy is defined by others: True leadership means focusing on impact, not recognition.Leadership evolves: Tripathi now leads with more listening, humility, and trust in his team than when he began.Great leadership isn't about the next job, it's about doing the current one with excellence.“If you're always thinking about the next job, you're not doing your current job well. Excellence now is what leads you forward.” – President Satish TripathiIf this conversation inspired you, share it with a colleague, subscribe for more wisdom-filled episodes, and take a moment to journal: what long-term impact are you building today?Learn more about the UIA by visiting:WebsiteLinkedInTwitterYouTubeFacebookThis week's episode is sponsored by Mainstay, a student retention and engagement tool where you can increase student and staff engagement with the only platform consistently proven to boost engagement, retention, and wellbeing. To learn more about Mainstay, click here.

Ever wondered what it takes to go from crunching numbers to creating worlds that millions of readers dive into?In the latest episode of Books & Beyond, Amish Tripathi shares the ups, downs, and behind-the-scenes of his journey from the 9-to-5 grind to bestselling author. From juggling a full-time job while writing Immortals of Meluha, to being one of the few authors in India who can write full time, he spills it all.Get a peek into his unique writing process: constant reading, letting characters “speak” to him, and rewriting until the story feels just right. He also shares insights for aspiring writers on how to navigate the journey of writing while staying true to their craft and managing the realities of the profession.Whether you're an aspiring author or just curious about the magic behind bestselling books, this episode is packed with insights, inspiration, and the twists and turns of Amish's writing journey.Tune in now and dive into the mind of one of India's most celebrated authors!Books mentioned in the episode:Ponniyin Selvan by Kalki KrishnamurthyBanbhatta Ki Atmakatha by Hazari Prasad DwivediRamayana by ValmikiMahabharata by Maharishi Ved Vyasa ‘Books and Beyond with Bound' is the podcast where Tara Khandelwal and Michelle D'costa uncover how their books reflect the realities of our lives and society today. Find out what drives India's finest authors: from personal experiences to jugaad research methods, insecurities to publishing journeys. Created by Bound, a storytelling company that helps you grow through stories. Follow us @boundindia on all social media platforms.

In this episode of the AI Chat podcast, host Jaeden Schaefer speaks with Brijesh, CEO of Flex AI, about the innovative solutions Flex AI is bringing to the AI infrastructure space. Brijesh discusses the vision behind Flex AI, which aims to create a universal AI platform that optimizes costs and improves efficiency for users. The conversation covers the challenges faced in AI engineering, and predictions for the future of AI infrastructure, emphasizing the importance of reducing costs to make AI more accessible.Try Flex AI: Flex.aiChapters00:00 Introduction to Flex AI and Brijesh's Background02:54 The Vision Behind Flex AI05:43 Innovations in AI Training and Inference08:17 Evolution of Flex AI and Market Positioning14:07 Challenges in AI Infrastructure20:47 Future Predictions for AI and Industry Trends

NASA astrophysicist and JPL Exoplanet Science Ambassador Anjali Tripathi joins Andy, Jesse and Matt to talk about exoplanets and the different ways of finding them including radial velocity, transits and gravitational microlensing, the challenges of studying planetary atmospheres, why telescopes are built in deserts or in space, Anjali's time at the White House Office of Science and Technology Policy, science communication projects like the Logic 44ever rap video, the upcoming Nancy Grace Roman Space Telescope, dark matter, lasers in astronomy, Halloween at the White House, the odd “smells” of other planets and how to take a virtual tour of JPL.

WBEN's Jim Fink speaks with A.J. Baynes, Amherst Chamber of Commerce CEO and president.

JCO PO authors Dr. Abhishek Tripathi and Dr. Salvador Jaime-Casas at City of Hope Comprehensive Cancer Center share insights into their article, “Comparative Genomic Characterization of Small Cell Carcinoma of the Bladder Compared With Urothelial Carcinoma and Small Cell Lung Carcinoma.”  Host Dr. Rafeh Naqash and Drs. Tripathi and Jaime-Casas discuss a novel understanding of the genomic alterations underlying SCBC, revealing actionable mutations that could serve as potential targets for improved clinical outcomes. TRANSCRIPT Dr. Rafeh Naqash: Hello and welcome to JCO Precision Oncology Conversations, where we bring you engaging conversations with authors of clinically relevant and highly significant JCO PO articles. I am your host, Dr. Dr. Rafeh Naqash, Podcast Editor for JCO Precision Oncology and Associate Professor at the OU Health Stephenson Cancer Center at the University of Oklahoma. Today, I am thrilled to be joined by Dr. Abhishek Tripathi, Associate Professor in the Department of Medical Oncology and Experimental Therapeutics Research at the City of Hope Comprehensive Cancer Center, as well as his mentee, Dr. Salvador Jaime-Casas, postdoctoral research fellow and first author of the JCO Precision Oncology article entitled "Comparative Genomic Characterization of Small Cell Carcinoma of the Bladder Compared with Urothelial Carcinoma and Small Cell Lung Carcinoma". At the time of this recording, our guest disclosures will be linked in the transcript. Abhishek and Salvador, welcome to our podcast and thank you for joining us today. This is a very interesting topic given that at least the landscape for neuroendocrine carcinomas, where small cell lung cancer is on one end of the spectrum, has been changing, at least on the lung cancer side, with recent approvals and some new ADCs. So, of course, understanding the genomic and transcriptomic similarities or differences between pulmonary small cell and extrapulmonary small cell is of huge interest. Could you tell us a little bit about small cell bladder cancer, current approaches to treatment of small cell bladder cancer, and then why you wanted to investigate that in this project as far as the genomic differences or similarities are concerned? Dr. Salvador Jaime-Casas: Well, first of all, thank you very much for having me. I am very excited to be here. And really what served as backbone for this research project was the notion that there is a currently evolving genomic landscape in the area of bladder cancer. We know this is a highly heterogeneous disease when it comes to molecular underpinnings and mutational profile. Specifically, we know that the most common histologic subtype is urothelial carcinoma. Small cell bladder cancer represents a histology that is found in less than 1% of all bladder cancer cases. However, it is one of the most aggressive histologies. It presents with a very poor prognosis to patients and very poor response to treatment, which is why we attempted to really elucidate what is the mutational profile behind this and provide a comparison contrast between small cell bladder cancer, small cell lung cancer, and conventional urothelial carcinoma. As your question mentioned, in terms of treatment, the conventional urothelial carcinoma and small cell bladder cancer are two distinct pathways when it comes to treatment algorithms. We know that in the current era there are newer and newer drugs being developed for conventional urothelial carcinoma. We have perioperative immunotherapy in the context of metastatic disease. We have antibody-drug conjugates such as enfortumab vedotin. But really, this amazing track record of drug development hasn't been mirrored in small cell bladder cancer. And here most of the therapy is usually extrapolated from studies from other small cell histologies like you mentioned earlier, small cell lung cancer has given some form of background in terms of what therapies are used here. Cytotoxic chemotherapy, for some patients with localized disease and small cell bladder cancer, concurrent chemotherapy and radiotherapy or perioperative cytotoxic chemotherapy have been the cornerstone of treatment for many years now. However, like I mentioned, the oncologic outcomes are very suboptimal when it comes to comparing it with other disease histologies, which is why we really wanted to describe the landscape here and provide this comparison across three different groups. For this particular study, we leveraged the Tempus dataset. So, include patients with urothelial carcinoma with small cell bladder cancer and small cell lung cancer. We included their demographic information, as well as the frequency of most common genomic alterations identified. And really, it was a very comparable Table 1. We see the demographic data across the three groups was very similar. One key thing that we identified was the female prevalence was a little bit lower in patients with small cell bladder cancer when compared to small cell lung cancer. But other than that, the age, race, ethnicity, was comparable across groups, and even the smoking history. Most of the patients in this cohort were former smokers, which we believe comes to explain that regardless of any mutational profile that we talked about in a few minutes, there are shared commonalities between these histologies and shared environmental exposures and risk factors that are going to be implicated in the disease biology for these three histologies. Dr. Rafeh Naqash: Thank you so much, Salvador, for that useful background. I would like to shift to Abhishek real quick. Abhishek, you are a practicing clinician, you have led several studies in the GU space, especially bladder. Based on what you see in the small cell lung cancer space, how drug development is shaping up, which aligns with what you are trying to evaluate in this paper as targets, how do you see some of that being implemented for small cell bladder cancer in the current era and age? Abhishek Tripathi: Thanks so much for the excellent question, Rafeh. As a GU investigator, small cell bladder cancer has always lagged behind in some regards regarding enrollment abilities for the novel clinical trials. And small cell lung cancer has paved the way and led the development of a lot of these drugs across the board. With the most recent sort of drugs targeting DLL3 already approved and several antibody-drug conjugates currently in development. That actually translates really well to how we should approach drug development in bladder cancer. What we saw in the study is that although there are overlaps and similarities between small cell lung cancer and small cell bladder cancer, there are also certain differences. So the long-term assumption that all therapies for small cell bladder cancer can be extrapolated to small cell bladder], may or may not be true, and I think it is high time that we specifically investigate these novel agents in tissue-specific small cell carcinomas. To that effect, we are excited to be participating in trials that are looking at some of the novel DLL3 targeted agents, specifically bispecific antibodies and T cell engagers so to speak, and antibody-drug conjugates that are now starting to open enrollment specifically in non-lung cancer cohorts to evaluate its efficacy. So overall, I think studies like this have the opportunity to identify more putative targets for organ-specific development of these novel agents. Dr. Rafeh Naqash: Absolutely, I could not agree more. I think tumor-agnostic therapies definitely have a place, but not all therapies work the same in different tumors with a similar histological or genomic background because there are definitely differences. So now going to the comparison that Salvador, you guys did in this project, could you help us understand what are some of the things you looked at, what were some of the commonalities and the differences, and what were some of the conceptual thoughts that come out from those results? Dr. Salvador Jaime-Casas: Of course. So, the first thing that we identified was which were the most frequent molecular alterations across these histologies. We actually provided a table showcasing how the most common mutations that we identified were TP53, TERT, RB1. However, like Dr. Tripathi mentioned, the distinction between these histologies is notable in the sense that some are more predominant in small cell-pertaining cancers such as bladder cancer and lung cancer. While some others are more common in bladder-pertaining malignancies like urothelial carcinoma and small cell bladder cancer. For instance, we saw that TP53 and RB1 were significantly more evident in small cell histologies, both small cell bladder cancer and small cell lung cancer, as opposed to conventional urothelial carcinoma, which really this mirrors what is known about these mutations and what has been published. These are markers associated with more aggressive disease with a worse prognosis and even to resistance to treatment. We also identified how TERT mutations were characteristically more prevalent in small cell bladder cancer as opposed to small cell lung cancer, as well as in urothelial carcinoma. TERT mutations were more commonly identified than in small cell lung cancer. And we give a long list of these mutations that we identified, but really what we wanted to underscore here was, A, the most common mutations across histologies; B, the most common co-occurring mutations where we saw that these are not mutually exclusive. A lot of patients had co-occurring TP53 and RB1 or RB1 and TERT or RB1 and ARID1A, really elucidating how heterogeneous this molecular landscape is across histologies. And the third one that we believe really brings down the clinical impact of this research was evidencing the idea of clinically actionable mutations. We also provided a table here showcasing how mutations like FGFR, DLL notch pathway, HER2, were evident in these histologies, and what is the current status of some clinical trials evaluating different drug designs for these mutations. Like Dr. Tripathi mentioned in the context of FGFR, approximately 6% of our cohort with small cell bladder cancer showcased mutations in FGFR3. However, up to 14% of them had mutations in any FGFR gene, which really underscores the notion that drugs like erdafitinib, which have been introduced in the market in recent years, could potentially showcase some response in the space of small cell bladder cancer. We actually provide the description of two trials, phase two, phase three trials, that are evaluating erdafitinib in the context of high-risk non-muscle invasive bladder cancer and even metastatic urothelial carcinoma. Like Dr. Tripathi mentioned as well, antibody-drug conjugates, another very interesting area of drug development targeting HER2, we included evidence on how disitamab vedotin and trastuzumab deruxtecan are currently being explored across different phase two and phase three clinical trials, both as part of basket trial designs for solid malignancies expressing HER2, but also for patients with urothelial carcinoma where there is evidence of HER2 expression. So, we believe that the landscape is shifting in the right direction in the sense that therapies are becoming much more personalized and targeted against these known molecular profiles. Dr. Rafeh Naqash: Thank you, Salvador, for summarizing some of those very interesting results and providing a very unique conceptual context to that. I would like to go to Abhishek this last portion. Of course, I am sure you guys will expand on this work and there are a lot of other interesting things that will likely come out from this work and hopefully you will publish that in JCO PO. But one of the very important things that I wanted to highlight from this podcast specifically was the science is obviously very interesting, but I feel the more important interesting aspect is giving trainees and fellows, residents, mentorship opportunities, mentoring them and giving them lead roles in projects like this, which is what Dr. Tripathi has successfully done for you in this project, Salvador. So, Abhishek, as somebody I have known for a couple of years now, more than a couple of years, as a very successful clinical translational investigator in the GU space in the early phase setting, Abhishek, really briefly, within a minute, could you tell us about your journey and what are some of the things that have worked for you as an early career investigator that you have learned from, and then your journey of mentorship, how has that been for you and what are some of the things that you take home from your mentorship role? Abhishek Tripathi: Absolutely. And as you mentioned, mentorship has been pivotal for all early career investigators for them to really succeed. So, my journey, as you know, I started off as an early career investigator at another institution, and I think I owe it to my mentors even at that time and even now who are helping me develop some of these newer translational and clinical trial ideas, creating opportunities where we could really showcase some of the interesting work that we are doing. That actually goes a long way in terms of creating independence as an established investigator. And I think the sooner we start off with mentorship prospects, I think the better it is. And paying it forward, I think I have been lucky to have mentees like Salvador who are just extremely talented, really committed, and goal-oriented. He really led the project right from the beginning in terms of initial analyses and looking up all the sort of correlative studies that we could do and the contextual data between small cell lung cancer and bladder cancer that we have delved into for the past several years. And it really showcases the ability of young mentees like Salvador to really excel given the right guidance and the support. As a mentor, it has been a really rewarding experience. It is really helpful to actually learn from some of these mentees as well as to approach the same problem from a different angle and different thought process and guide them through the study. So, it has been incredibly helpful and rewarding both being a mentee and a mentor over the past several years as I have transitioned. Dr. Rafeh Naqash: Thank you, Abhishek, for those very insightful comments on how both being a mentee and being a mentor helps shape you as an individual as well. And then you take a lot of pride in the success of your mentees. Now real quick, Salvador, could you tell us a little bit about yourself, you know, how you ended up at City of Hope under Dr. Tripathi's mentorship and what are some of the next important things that you are looking forward to doing? Dr. Salvador Jaime-Casas: So, a little bit about who I am. I did medical school in Mexico City. I was born and raised there, and towards the end of my medical training, I started to be engaged in research projects. And through one of my mentors in Mexico, I was actually introduced to the team here at City of Hope, including Dr. Tripathi. And through this, we got the opportunity to have some conversations about what I wanted to do, become a physician-researcher in the area of genitourinary oncology and hopefully my transition to residency in a few years. And that is how I came to be his mentee here at City of Hope. I think it has been a very rewarding experience, like Dr. Tripathi said, having such an incredible mentor and really being with him both in the academic setting and in the clinical setting, in patients with clinic, seeing this curiosity and all these clinical trials, all of this evidence that we have coming together to generate this insight. Dr. Rafeh Naqash: Thank you so much for both the scientific insights, as well as the journey of being a mentee for you, Salvador, and as a mentor for you, Abhishek. I really enjoyed talking to you guys about both aspects here today and hopefully we will see more of your work, Abhishek and Salvador, as far as understanding the transcriptomic heterogeneity in neuroendocrine tumors or neuroendocrine cancers of the bladder. Dr. Salvador Jaime-Casas: Thank you very much. Thank you for having us. Dr. Rafeh Naqash: Thank you for listening to JCO Precision Oncology Conversations. Do not forget to give us a rating or review and be sure to subscribe so you never miss an episode. You can find all ASCO shows at ASCO.org/podcasts. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity or therapy should not be construed as an ASCO endorsement.   Dr. Abhishek Tripathi Disclosures Consulting or Advisory Role:  Company: Aadi biosciences, Seattle Genetics/Astellas, Exelixis, Bayer, Gilead Sciences, Pfizer, Deka biosciences Speakers' Bureau: Company: Sanofi

Want a jawline that turns heads from every angle? Dr. Prem Tripathi, double board-certified facial plastic surgeon, is back to talk neck contouring - a popular procedure for neck and jawline enhancement! This procedure could help sculpt and give incredible definition, making it a perfect option for patients seeking dramatic results. Dr. Tripathi discusses everything from who would make ideal candidates to recovery timelines.   Care Experts is a weekly podcast by CareCredit where we sit down with doctors and experts who give information, tips and insight into healthcare treatments and procedures. Check in every Wednesday for new episodes at carecredit.com/careexperts or follow on your favorite podcast app.   CareCredit is a health, wellness and personal care credit card that has helped millions of people with promotional financing options and is accepted at hundreds of thousands of provider and retail locations nationwide. Learn more at carecredit.com.

Looking for a brighter, more refreshed look? Then you're in the right place! Dr. Prem Tripathi, double board-certified facial plastic surgeon, joins us to talk eyelid surgery—a go-to procedure for reducing puffiness, lifting sagging lids, and rejuvenating tired eyes. He explains how this quick treatment can help create more balanced, youthful results with minimal downtime. Dr. Tripathi also shares his signature approach, the winged blepharoplasty technique, designed to enhance the shape of the eyes while keeping the results natural.   Care Experts is a weekly podcast by CareCredit where we sit down with doctors and experts who give information, tips and insight into healthcare treatments and procedures. Check in every Wednesday for new episodes at carecredit.com/careexperts or follow on your favorite podcast app.   CareCredit is a health, wellness and personal care credit card that has helped millions of people with promotional financing options and is accepted at hundreds of thousands of provider and retail locations nationwide. Learn more at carecredit.com.

Could a new telescope one day spot city lights on exoplanets? Neil deGrasse Tyson and comedian Matt Kirshen answer questions about the frontiers of exoplanet science with astrophysicist and NASA Exoplanet Science Ambassador, Anjali Tripathi. NOTE: StarTalk+ Patrons can listen to this entire episode commercial-free here: https://startalkmedia.com/show/searching-for-alien-worlds-with-anjali-tripathi/Thanks to our Patrons William Dusenberry, Renee Lehmann, Angelina Vaquera-Linke, Mokonabarb, Sean Legnini, Adam Dylan, Zack Goss, Hannah Jarrells, Adith Dev Reddy, Christopher Bolin, Smarty Pants Cafe, Berhtrahmn Gregor, Alexander Hopkins, Duane, Dominik Heinrich, Anton Hansen, Peter J Fitzpatrick, Jedi - the i is silent, Balaji Narayanaswami, Jim Liggett, Tarek Hijaz, Josie Hall, JoshoohAhh, Sami Elderazi, James Grayson, J Brett Cunningham, GryphonDS, Russell r, Jason Moet, Kristina Gizzo, Travis Dodson, Larry Lee, John Pilger, Andy Fry, Micheal Johnson, Dylan Nazzal, Daniel Norton, AJ Stavely, Erik D. Aranda-Wikman, tsuribachi, WIlliam Lubak, Brennen, and Jo-el Armstrong for supporting us this week. Subscribe to SiriusXM Podcasts+ to listen to new episodes of StarTalk Radio ad-free and a whole week early.Start a free trial now on Apple Podcasts or by visiting siriusxm.com/podcastsplus.

Meltdown of Pakistan Lovers in India  | Chitra Tripathi Controversy | Where is Rahul Gandhi? | Bihar

Highlights from our conversation with Founder and Publisher of Kokila, Namrata Tripathi:   The power of celebrating not just our communal work, but also ourselves Voice as an essential point of view with no illusion of neutrality How cheap workarounds subvert the hard work of uncovering our own voice  The power of words like “intuition” (despite how it may come off as fluffy or weak) Supporting writers in identifying who they are actually in conversation with on the page The lifelong work of knowing how to be more honest with ourselves and the world The priceless bit of publishing wisdom a former boss shared How Kokila's intentional approach to each facet of publishing is intrinsically tied to the books they put out into the world.   Namrata Tripathi is Founder and Publisher of Kokila. Previously, Namrata held editorial positions at HarperCollins, Disney-Hyperion, and Simon and Schuster. She is the editor of New York Times bestsellers Hair Love by Matthew A. Cherry and Vashti Harrison and Antiracist Baby by Ibram X. Kendi and Ashley Lukashevsky; the Newbery Honor-winning middle grade novel The Night Diary by Veera Hiranandani; and the National Book Award Finalists Noggin by John Corey Whaley, Patron Saints of Nothing by Randy Ribay, and The Legend of Auntie Po by Shing Yin Khor. Namrata grew up in Afghanistan, India, Canada, Pakistan, Germany, and Poland, and has happily called New York City home for the last twenty-five years.

In this episode with Salil Tripathi, Part 2, joining Amit Dosh for a Global Politics discussion on how the US and China dominate global power dynamics, Tripathi ties these themes into India’s struggle with free speech and rising religious nationalism, as explored in his book Offence: The Hindu Case. Tripathi underscores the erosion of India’s secular ideals, urging a return to pluralism and robust legal safeguards for artistic freedom against politicized censorship. This analysis serves as a timely warning against the dangers of religious extremism and the state’s complicity in undermining democratic values.Elon Musk & Donald Trump are dominating the US vs China game. How India with Modi is making a path for global image. Are we paving the way for future? Find out in the episode.See omnystudio.com/listener for privacy information.

- The Best Cricket Stories - Daily! - https://bestofcricket.substack.com/- Get an exclusive 15% discount on Saily data plans! Use code 'goodareas' at checkout. Download Saily app or go to:https://saily.com/goodareas-This week on Wagon Wheel Jarrod talks about the fields in cricket that teams don't use as often as they should. Who was better Bhuvi or Shami? Should CSK stick with Tripathi at the top. What the IPL could do to improve its brand, and why the impact player is stupid. And finally why did Stuart Surridge never get an England cap and captain England.-To support the podcast please go to our Patreon page. https://www.patreon.com/user?u=32090121. Jarrod also now has a Buy Me A Coffee link, for those who would prefer to support the shows there: https://www.buymeacoffee.com/jarrodkimber.Each week, Jarrod Kimber hosts a live talk show on a Youtube live stream, where you can pop in and ask Jarrod a question live on air. Find Jarrod on Youtube here: https://www.youtube.com/c/JarrodKimberYT.To check out my video podcasts on Youtube : https://youtube.com/@JarrodKimberPodcasts-This podcast is edited and mixed by Ishit Kuberkar, he's at https://instagram.com/soundpotionstudio & https://twitter.com/ishitkMukunda Bandreddi is in charge of our video side.

In this episode of Brown Enough, comedian Pooja Tripathi joins usfor a deep (and hilarious) dive into creativity, art, humor, coffee culture, and all things New York. Her BK Coffee Shop videos have racked up millions of views and a feature in The New York Times. Pooja has mastered the fine line between satire and reality—especially with her viral collaborations that “don't exist but sort of do.” We unpack the magic of making something from nothing, the absurdity of the internet, and why everyone should probably go buy one of collabs. Tune in for laughs, insights, and a little creative mischief.

In this episode, we sit down with Amish Tripathi, bestselling author and cultural thought leader, to discuss the resurgence of spirituality in India, the West's misunderstandings of Hinduism, and the urgent need to reclaim India's historical narrative. From his viral Oxford Union debate to his take on India's evolving identity, Amish offers powerful insights into how ancient wisdom is shaping the modern world. Topics: 00:00 - Introduction 02:10 - Why Millions Are Turning to Spirituality 06:45 - West vs. India: The Binary vs. Nuanced Thinking 12:30 - Why India's Economic Rise Fuels Cultural Confidence 18:15 - Oxford Union Debate: Defending Hinduism Against Atheists 23:40 - Colonial Lies & Misconceptions About Hinduism 30:10 - Who Really Wrote Indian History? The British Narrative Exposed 35:45 - The Role of Sadhus: Why They're NOT Like Western Monks 41:20 - Why India Respects Selfless Leaders Like Modi & Yogi 47:05 - How Hinduism Adapts While Abrahamic Religions Struggle 52:30 - The Power of Rituals & Why They Matter Today 58:45 - From Author to Filmmaker: Amish's Journey Into Documentaries 1:05:20 - Final Thoughts: What the West Can Learn from Hinduism

Exploring NASA, SpaceX, and the Evolution of Space Ventures with Abhi Tripathi Secure World Foundation is thrilled to announce the release of the fifth episode of "ESG in Space," a podcast series in collaboration with Exponential Academy, hosted by Nishan Degnarain and Miki Sode. This episode features a fascinating discussion with Abhi Tripathi, Director of Mission Operations at UC Berkeley's Space Sciences Lab. In this episode, Abhi discusses his journey through the space sector, from his early days at NASA to key roles at SpaceX, and now leading mission operations at UC Berkeley. He shares his unique insights on the transition of space activities from government-dominated initiatives to vibrant commercial enterprises and discusses the critical role of government and military funding in nurturing the nascent commercial space industry. Listen to "ESG in Space" Episode 3 here or on our YouTube Channel to gain a deeper understanding of the complexities and potential of commercial space ventures. Recorded January 29, 2025

The Champions Trophy is upon us, and in this episode, we delve into the intricacies of this prestigious tournament with a keen focus on the dynamics of the competing teams. Host Mayank engages in a substantive dialogue with Gaurav Tripathi, sub-editor at Cricket.com, as they explore the strengths and weaknesses of the various squads, dissecting the implications of their recent performances. The conversation highlights the significance of team compositions and the impact of player injuries, particularly for powerhouses like India and Australia. Furthermore, they scrutinize the potential dark horses of the tournament and assess how emerging teams like Afghanistan could disrupt the conventional hierarchy. Join us as we navigate the complexities of the Champions Trophy and offer our predictions for this highly anticipated event.Takeaways: The Champions Trophy garners significant attention as top international teams compete, reviving rivalries and generating excitement. The relevance of the Champions Trophy is questioned due to the declining frequency of ODI matches played by teams. India, while a strong contender, faces challenges in their bowling lineup, particularly with the absence of key players like Bumrah. Pakistan's unpredictable nature and fluctuating performance pose potential challenges for their success in the tournament. New Zealand is viewed as a dark horse, capable of overachieving despite not being seen as the strongest on paper. Afghanistan's spinners are expected to play a crucial role in their potential success at the Champions Trophy, given their recent form. LinkGaurav Nandan Tripathi | गौरव नंदन त्रिपाठी (@Cric_Beyond_Ent) / X

For the past 20 years, under both Republican and Democratic administrations, the ONC has played a pivotal role shaping and regulating the health tech market. On the eve of the election, Micky Tripathi joined me to discuss the agency's recently expanded role. Now, two months later—though it feels like a decade—the future is uncertain. Will the ONC and ASTP continue as market regulators and opportunity catalysts, or is a new direction on the horizon?Here's what we covered:The government's role in shaping and regulating the health tech ecosystemAI in healthcare: balancing the risks of misuse vs. the risk of “missed uses” Health information sharing: why Micky is optimistic about the future Can technology take the pain out of prior auth?Micky thinks we are standing on the edge of a transformative era:“We are just at the beginning of the most exciting decade...health information technology can really start to show… the return on investment for patients. We've done a lot of hard work over the last 10 years… [With that foundation in place] we have the opportunity to say there's an ROI here for patients.”Relevant LinksBlog post on ONC reorganization: ONC's Next ChapterTEFCA overviewForbes interview: Where is interoperability headed?Healthcare Dive: HHS AI Task Force Takes Shape (March 2024)Blog post by Micky: Getting real about information blocking and APIs (October 2024)About Our GuestMicky Tripathi is the Assistant Secretary for Technology Policy, National Coordinator for Health Information Technology, and Acting Chief Artificial Intelligence Officer at the U.S. Department of Health and Human Services, where he leads the formulation of HHS technology and data strategy and coordinates technology policies, standards, programs, and investments.Dr. Tripathi has over 20 years of experience across the health IT landscape. Prior to joining the federal government he served as Chief Alliance Officer for Arcadia, a health care data and software company focused on population health management and value-based care, the project manager of the Argonaut Project, an industry collaboration to accelerate the adoption of FHIR, and a board member of HL7, the Sequoia Project, the CommonWell Health Alliance, and the CARIN Alliance.Dr. Tripathi served as the President and Chief Executive Officer of the Massachusetts eHealth Collaborative (MAeHC), a non-profit health IT advisory and clinical data analytics company. He was also the founding President and CEO of the Indiana Health Information Exchange, a statewide HIE partnered with the Regenstrief Institute, an Executive Advisor to investment firm LRVHealth, and a Fellow at the Berkman-Klein Center for Internet and Society at Harvard University.He holds a PhD in political science from the Massachusetts...

Host Dr. Jay Anders invites back Micky Tripathi, PhD, MPP, the current Assistant Secretary for Technology Policy, National Coordinator for Health Information Technology, and Acting Chief Artificial Intelligence Officer for a look back and forward for the ONC. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Vinay Tripathi, a senior network engineer in Google Backbone Engineering and an 18-year network engineering veteran, discusses BGP optimization, a technique that's critical in achieving top goals in distributed applications. Host Philip Winston speaks with Tripathi about BGP, autonomous systems, peer grouping, router hardware and software, software-defined networks, and shared network optimization and debugging stories. Brought to you by IEEE Computer Society and IEEE Software magazine.

The topic “Politics 2029” examines the potential political landscape of India leading up to 2029, focusing on emerging trends, leadership changes, and the influence of key issues like economy, governance, and social dynamics. It explores how current political alliances, voter behavior, and global factors may shape the future of Indian politics, offering insights into what could define the nation's direction in the coming decade.

Learn more about the UIA by visiting: Website LinkedIn Twitter YouTube Facebook This week's episode is sponsored by Mainstay, a student retention and engagement tool where you can increase student and staff engagement with the only platform consistently proven to boost engagement, retention, and wellbeing. To learn more about Mainstay, click here.

Check out the latest episode of LevelUp Cyber where I sit down with Gitesh Tripathi, a recent college graduate who's already making waves in the cybersecurity world. Gitesh's journey into cybersecurity is unique and inspiring—especially considering his international background, which adds a global perspective to his approach. We'll dive into his experience navigating the post-grad landscape, breaking into the cybersecurity field, and the steps he took to get there. Whether you're a recent grad or a professional looking to pivot, you won't want to miss this! Stay tuned for the full conversation. #LevelUpCyber #CybersecurityCareers #CyberUp #GlobalTech #CyberTalent #SkillsBasedHiring

In this episode of 'The Dave and Darm demystify show,' special guest Abhishek Tripathi, Head of Product at Careem Pay, discusses his role and Careem's evolution from a ride-sharing app to an 'everything app' offering over 15 services, including payments, food delivery, and more across 10 countries and 80 cities. Abhishek explains Careem's efforts in solving payment challenges and its approach to building FinTech products by collaborating closely with customers. Highlighting Careem Pay's rapid growth, especially in international remittances, he underscores the importance of customer trust and seamless digital experiences. Abhishek also touches on Careem's mission-driven structure, their proactive use of AI for enhancing user experience, and the significance of strategic partnerships in delivering diverse services. The conversation delves into the broader implications for traditional banks and the potential future trajectory of FinTech innovations.

In this episode of the UB School of Management podcast, co-hosts Patrick Lageraaen and Eric Raine interview University at Buffalo President Satish K. Tripathi. They discuss the role of the president, his journey from growing up in India to becoming president at UB, and initiatives such as the Empire AI consortium. Discover the multifaceted role of a university president as Tripathi shares his experiences, daily responsibilities, and his unwavering commitment to UB's mission of excellence in research, education, and community service. President Tripathi highlights the significant contributions of the School of Management, particularly in fostering entrepreneurship, leadership training, and community engagement. Gain insights into his dedication to inclusivity and the university's vital role in enhancing the prosperity of Western New York. Tripathi explains that UB's strategic vision is to become one of the top 25 public research universities, and he discusses the importance of student success, faculty recognition, and social impact in achieving this goal.

The Office of the National Coordinator for Health IT has its sights set on advancing health equity through “Health Equity By Design” and U.S. Core Data Interoperability standards to ensure that everyone has fair and equal access to the highest quality of health care regardless of race, gender, disability, location and a host of other factors. Artificial intelligence is also playing a pivotal role in helping agencies achieve national health goals. Recently appointed acting chief AI officer of the Department of Health and Human Services, Tripathi said AI is helping to close health equity gaps when it comes to analytics, determining patient demographics and informing decision-making for treating patients. Tripathi also highlighted ONC's collaborative efforts with the Centers for Disease and Control and Prevention (CDC) and other agencies that are improving interoperability and the integration of public health data.

Hridayesh Tripathi, a Nepalese politician, presently holds the position of President of the People's Progressive Party, having previously served as the Minister of Health and Population.

Welcome to The Nonlinear Library, where we use Text-to-Speech software to convert the best writing from the Rationalist and EA communities into audio. This is: "Cool Things Our GHW Grantees Have Done in 2023" - Open Philanthropy, published by Lizka on May 13, 2024 on The Effective Altruism Forum. Open Philanthropy[1] recently shared a blog post with a list of some cool things accomplished in 2023 by grantees of their Global Health and Wellbeing (GHW) programs (including farm animal welfare). The post "aims to highlight just a few updates on what our grantees accomplished in 2023, to showcase their impact and make [OP's] work a little more tangible." I'm link-posting because I found it valuable to read about these projects, several of which I hadn't heard of. And I like that despite its brevity, the post manages to include a lot of relevant information (and links), along with explanations of the key relevant theories of change and opportunity. For people who don't want to click through to the post itself, I'm including an overview of what's included and a selection of excerpts below. Overview The post introduces each program with a little blurb, and then provides 1-2 examples of projects and one of their updates from 2023. Here's the table of contents: 1. Global Public Health Policy 1. Dr. Sachchida Tripathi (air quality sensors) 2. Lead Exposure Elimination Project (LEEP) 2. Global Health R&D 1. Cures Within Reach 2. SAVAC 3. Scientific Research 1. Dr. Caitlin Howell (catheters) 2. Dr. Allan Basbaum (pain research) 4. Land Use Reform 1. Sightline Institute 5. Innovation Policy 1. Institute for Progress 2. Institute for Replication 6. Farm Animal Welfare 1. Open Wing Alliance 2. Aquaculture Stewardship Council 7. Global Aid Policy 1. PoliPoli 8. Effective Altruism (Global Health and Wellbeing) 1. Charity Entrepreneurship 9. How you can support our grantees Examples/excerpts from the post I've chosen some examples (pretty arbitrarily - I'm really excited about many of the other examples, but wanted to limit myself here), and am including quotes from the original post. 1.1 Dr. Sachchida Tripathi (air quality sensors) Sachchida Tripathi is a professor at IIT Kanpur, one of India's leading universities, where he focuses on civil engineering and sustainable energy. Dr. Tripathi used an Open Philanthropy grant to purchase 1,400 low-cost air quality sensors and place them in every block[2] in rural Uttar Pradesh and Bihar. Using low-cost sensors involved procuring and calibrating them (see photo). These sensors now provide much more accurate and reliable data for these rural areas than was previously available to the air quality community. This work has two main routes to impact. First, these sensors make the problem of rural air pollution legible. Because air quality in India is assumed to be a largely urban issue, most ground-based sensors are in urban areas. Second, proving the value of these low-cost sensors and getting operational experience can encourage buy-in from stakeholders (e.g., local governments) who may fund additional sensors or other air quality interventions. Air quality monitoring is a major theme of our South Asian Air Quality grantmaking. We are actively exploring opportunities in new geographic areas, both within and beyond India, without high-quality, ground-based monitoring. Santosh Harish, who leads our grantmaking on environmental health, recently spoke to the 80,000 Hours podcast about this grant as well as air quality in India more generally. 2.2. SAVAC (accelerating the development and implementation of strep A vaccines) The Strep A Vaccine Global Consortium (SAVAC) is working to accelerate the development and implementation of safe and effective strep A vaccines. Open Philanthropy is one of very few funders supporting the development of a group A strep (GAS) vaccine (we've funded two projects to test new vaccines). GAS kills over 500,000 people per year, mostly by causing rheumatic heart disease.[3] Wh...

Is reincarnation a real thing? Does possession - not the demonic kind - happen more then we think it does? A case in India back in 1985 may hold the answers... Learn more about your ad choices. Visit megaphone.fm/adchoices

This episode of Enabling Health Value showcases the US National Coordinator for Health IT, Micky Tripathi. He leads the Office of the National Coordinator (or the ONC) – a staff ...

Listen as Impressive's Russ Macumber talks with Bob Tripathi of Digital Sparxhttps://digitalsparxmarketing.com/

In this episode, Dr. Micky Tripathi, National Coordinator for Health Information Technology at the Department of Health and Human Services (HHS), shares how AI can improve patient care, current work at HHS to implement the WH Executive Order on AI, the potential risks that AI presents to the healthcare system and how transparency can improve AI outcomes in the healthcare space. 

1) How Myrto arrived at energy, specifically nuclear energy, as the root enabler of prosperity 2) Voices of Nuclear, it's mission and vision, and recent updates 3) A deep dive into the Voices of Nuclear “Energy Transition Scenario” and the relationship between innovation and progress 4) The symbolism and messaging of Voices and what they see for the future of nuclear energy

Have you ever faced a setback that seemed insurmountable, only to emerge stronger and more successful than you ever imagined? This episode offers a riveting tale of Dr. Prem Tripathi's extraordinary transformation from job loss to launching a thriving private practice, demonstrating the sheer force of starting before you're ready. With my new book, "Visibility Formula," as a backdrop, we unpack the principles that powered Dr. Tripathi's pivot from being fired to creating a private practice that raked in $75,000 within the first ten business days—an achievement that shines as a beacon of hope for physicians embarking on similar entrepreneurial paths.Drawing on the proactive mindset and astute business acumen that Dr. Tripathi honed in business school, this episode takes you through the steps of brand building and strategic visibility that are critical for success in today's digital age. Witness how leveraging social media, creating strong networks, and preparing for opportunities before they arise can lead to exponential growth and resilience. This narrative is not just a blueprint for financial triumph but a compelling reminder of the power inherent in embracing adversity as a platform for innovation and change—principles that have the potential to ignite a transformative journey for any physician ready to take the leap into entrepreneurship. Join us for a story of courage, strategy, and the undeniable impact of forging ahead, even when the path seems unclear.When you are ready to work with us, here are three ways.1. EntreMD Business School Accelerator - If you are looking to make a 180 turnaround in your business in 90 days, this is the program for you. 2. EntreMD Business School Grow - This is our year-long program with a track record of producing physician entrepreneurs who are building 6, 7 and 7+ figure businesses. They do this while building their dream lives!3. EntreMD Business School Scale - This is our high-level mastermind for physicians who have crossed the seven figure milestone and want to build their businesses to be well oiled machines that can run without them.To get on a call with my team to determine your next best step, go here www.entremd.com/callFollow Dr. Una hereLinkedIn - www.linkedIn.com/in/druna Facebook - https://www.facebook.com/drunachukwuInstagram - https://www.instagram.com/drunachukwuYouTube - https://www.youtube.com/@DrUnachukwu

January 12th, 2023: This conversation with Micky Tripathi, National Coordinator for Health Information Technology at ONC, explores the intricate balance between policy, technology, and business within healthcare. How is the intersection of these domains reshaping healthcare IT, and what challenges and rewards come with navigating this nexus? They also touch upon the implications of the 21st Century Cures Act and the role of information blocking in modern healthcare. What does the future hold for health IT professionals in the wake of these regulatory changes, and how will these adjustments impact patient care and provider interactions? Furthermore, the discussion highlights the potential of TEFCA (The Trusted Exchange Framework and Common Agreement) in revolutionizing health information exchange. Could TEFCA be the key to overcoming previous communication barriers in public health emergencies? Join us as we explore these pivotal topics and their implications for the future of healthcare.Key Points:Home Based CareInformation Blocking RegulationsTEFCA and Public HealthPatient and Provider InteractionEthics of Sharing InformationSubscribe: This Week HealthTwitter: This Week HealthLinkedIn: Week HealthDonate: Alex's Lemonade Stand: Foundation for Childhood Cancer

On today's episode of Gist Healthcare Daily, we hear the second part of JC's conversation with Micky Tripathi, National Coordinator for Health Information Technology at the U.S. Department of Health and Human Services, about proposed penalties for healthcare providers that engage in information blocking and how they fit into the federal government's overall interoperability goals. You can find the first part of our conversation here. You can read HHS' proposed rule here. Hosted on Acast. See acast.com/privacy for more information.

Is Earth going to evaporate? Neil deGrasse Tyson and comedian Chuck Nice learn about exoplanet discovery, planetary evaporation, biosignatures and technosignatures with astrophysicist Anjali Tripathi.NOTE: StarTalk+ Patrons can listen to this entire episode commercial-free here:https://startalkmedia.com/show/habitable-worlds-super-earths-evaporating-planets-with-anjali-tripathi/Thanks to our Patrons Christopher Stowe, Bo Cribbs, Jennifer Pierce, Sam Gilbert, Steven Glasser, Antonio Garibay, and David Frigoletto for supporting us this week.Photo Credit: ESA/Hubble, CC BY 4.0, via Wikimedia Commons

National Coordinator for Health IT at the US Department of Health and Human Services, Dr. Micky Tripathi joins the Glaucomfleckens talk about improving interoperability, graveyard shifts at the ER, and have a ton of laughs along the way. — Want to Learn About Dr. Micky Tripathi?  Twitter: @mickytripathi1 — We want to hear YOUR stories (and medical puns)! Shoot us an email and say hi! knockknockhi@human-content.com Can't get enough of us? Shucks. You can support the show on Patreon for early episode access, exclusive bonus shows, livestream hangouts, and much more! – www.patreon.com/glaucomflecken  -- A friendly reminder from the G's and Tarsus: If you want to learn more about Demodex Blepharitis, making an appointment with your eye doctor for an eyelid exam can help you know for sure. Visit EyelidCheck.com for more information. Today's episode is brought to you by the Nuance Dragon Ambient Experience (DAX). It's like having a virtual Jonathan in your pocket. If you would like to learn more about DAX, check out http://nuance.com/discoverDAX and ask your provider for the DAX experience. Produced by Human Content Learn more about your ad choices. Visit megaphone.fm/adchoices

In the days after the 2013 Boston bombing, an online hunt for the perpetrators falsely accused Brown University student Sunil Tripathi. Police later discovered that Tripathi, who had been showing signs of depression, had died by suicide. Endless Thread revisits his story — one of family and mental health — on the 10th anniversary with documentarian Neal Broffman and Tripathi's sister, Sangeeta Tripathi. Editor's note: This story mentions suicide. You can reach the Suicide and Crisis Lifeline toll-free by calling or texting 988. ***** Credits: This episode was produced by Dean Russell. Mix and sound design by Emily Jankowski. Amory Sivertson and Ben Brock Johnson are the co-hosts.